Sanchez, Faith .
HRN: 26-14-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/16/2026
07/23/2026
IV
100mg
Q8H
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes